Clinical Trials

Showing 61 - 80 of 508 trials
Titlesort icon Investigator Disease(s)
Cabozantinib versus Sunitinib for Treating Previously Untreated Locally Advanced or Metastatic Renal Cell Cancer
[Protocol 14-072]
Feldman, Darren
  • Kidney Cancer
Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLA-Compatible Donor
[Protocol 12-053]
O'Reilly, Richard
  • Blood & Marrow Stem Cell Transplantation
  • Hematology
    • Hematologic Disorders
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
    • Chronic Myelocytic Leukemia
    • Myelodysplastic Syndrome
  • Lymphoma
    • Non-Hodgkin's Lymphoma
Biological, Behavioral, and Sociodemographic Characteristics of Long-Term Survivors of Ovarian Cancer
Newly Diagnosed & Relapsed/Refractory
[Protocol 14-224]
Carter, Jeanne
  • Ovarian Cancer
  • Survivorship
Assessment of Heart Tissue in Survivors of Hodgkin Lymphoma
[Protocol 14-017]
Matasar, Matthew
  • Lymphoma
    • Hodgkin's Disease
  • Survivorship
Assessment of a Customized Computer Program for Reducing Fears of Breast Cancer Recurrence
[Protocol 11-204]
Lichtenthal, Wendy
  • Breast Cancer
  • Psychiatry & Behavioral Sciences
  • Survivorship
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
[Protocol 00-069]
Offit, Kenneth
  • Hereditary Cancer & Genetics
  • Leukemia
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
Analysis of Blood and Salivary Samples for Genetic Studies of Familial Cancers
[Protocol 93-102]
Offit, Kenneth
  • Hereditary Cancer & Genetics
An Observational Study of Treatment Patterns and Outcomes in Patients with Advanced Basal Cell Carcinoma or Basal Cell Carcinoma Nevus Syndrome
[Protocol 13-221]
Lacouture, Mario
  • Basal Cell Carcinoma
ALTE03N1: Key Adverse Events Following Childhood Cancer
[Protocol 05-070]
Sklar, Charles
  • Survivorship
Adoptive Transfer of Autologous T Cells Targeted to Prostate-Specific Membrane Antigen for the Treatment of Metastatic Castration-Resistant Prostate Cancer
[Protocol 09-036]
Slovin, Susan
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
Adherence to Comprehensive, Multi-Organ Screening Recommendations in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients
[Protocol 04-144]
Stadler, Zsofia
  • Colorectal Cancer
    • Colon Cancer
  • Hereditary Cancer & Genetics
  • Psychiatry & Behavioral Sciences
Adaptation of Meaning-Centered Psychotherapy for Chinese Immigrant Cancer Patients
[Protocol 14-076]
Leng, Jennifer
  • Psychiatry & Behavioral Sciences
Acupuncture for Chronic Lymphedema After Breast Cancer Treatment
[Protocol 12-210]
Cassileth, Barrie
  • Breast Cancer
  • Quality of Life
  • Survivorship
A Two-Stage Pilot Study of PEGPH20 and Cetuximab in Patients with Pancreatic Cancer When Given Before Tumor Removal
[Protocol 14-039]
Yu, Kenneth
  • Hepatobiliary
    • Pancreatic Cancer
  • Upper Gastrointestinal
    • Pancreatic Cancer
A Study to See if Mesothelin Can Serve as a Marker of Early Lung Cancer
Newly Diagnosed
[Protocol 13-262]
Rizk, Nabil
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Study Offering Treatment with 3F8 and GM-CSF in Patients with High-Risk Neuroblastoma
[Protocol 13-260]
Kushner, Brian
  • Neuroblastoma
A Study of Vorinostat (SAHA) plus Isotretinoin and Chemotherapy in Infants and Young Children with Embryonal Tumors of the Central Nervous System
[Protocol 12-191]
Kramer, Kim
  • Pediatric Brain Tumors
    • Brain Cancer
A Study of the Biologic Effects of Nivolumab (BMS-936558) in Patients with Inoperable or Metastatic Melanoma
[Protocol 12-231]
Wolchok, Jedd
  • Melanoma
A Study of Posaconazole Versus Micafungin to Protect Against Invasive Fungal Infections in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia or Myelodysplastic Syndrome
[Protocol 10-038]
Papanicolaou, Genovefa
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
A Study of Physician Communication Skills to Promote Patients' Transition to Survivorship
[Protocol 11-180]
Horwitz, Steven
  • Lymphoma
  • Quality of Life
  • Survivorship